K232898 is an FDA 510(k) clearance for the Quantisal™ Oral Fluid Collection Device. Classified as Oral Fluid Drugs Of Abuse And Alcohol Test Specimen Collection Device (product code PJD), Class II - Special Controls.
Submitted by Immunalysis Corporation (Pomona, US). The FDA issued a Cleared decision on November 21, 2023 after a review of 64 days - a notably fast clearance cycle.
This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1675 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Immunalysis Corporation devices